Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05230511 · ClinicalTrials.gov registry record · Phase 2

Intravesical LGG VS Saline Bladder Wash RCT

A Phase 2 study of Spinal Cord Injuries and Neurogenic Bladder, sponsored by Medstar Health Research Institute.

Recruiting
Registry status
Phase 2
Development phase
120
Enrollment target
1
Study location

NCT05230511 is a Phase 2 study of Spinal Cord Injuries and Neurogenic Bladder that is actively recruiting participants, run by Medstar Health Research Institute. The registered enrollment target is 120 participants, above the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (97% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05230511, a Phase 2 study of Spinal Cord Injuries and Neurogenic Bladder, is actively recruiting participants, sponsored by Medstar Health Research Institute.

RECRUITING
Registry status
Phase 2
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

This is the first ever comparative effectiveness study of an antibiotic-sparing novel self-management intervention to prevent complicated urinary tract infection (UTI).

Interventions

  • DRUG Lactobacillus RhamnosusGG
  • DRUG Saline bladder wash

Study Locations (1)

District of Columbia

  • MedStar National Rehabilitation Hospital - Washington D.C.

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2022-06-13
Est. Completion 2026-12-31
Phase Phase 2

Sponsor

Medstar Health Research Institute

115 total trials

What the Registry Record Tells You About NCT05230511

The ClinicalTrials.gov registry entry for NCT05230511 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (97% higher). The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Spinal Cord Injuries appearing as the primary indexed condition, and to 2 interventions - of which Lactobacillus RhamnosusGG is the first listed.

NCT05230511 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.

Frequently Asked Questions

What is clinical trial NCT05230511 about?

NCT05230511 is a clinical study titled "Intravesical LGG VS Saline Bladder Wash RCT". This is the first ever comparative effectiveness study of an antibiotic-sparing novel self-management intervention to prevent complicated urinary tract infection (UTI).

What is the current status of trial NCT05230511?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 2022-06-13. Estimated completion is 2026-12-31.

What conditions does trial NCT05230511 study?

This clinical trial studies the following conditions: Spinal Cord Injuries, Neurogenic Bladder.

What interventions are being tested in trial NCT05230511?

The interventions under investigation include: Lactobacillus RhamnosusGG (DRUG), Saline bladder wash (DRUG).

Who is sponsoring clinical trial NCT05230511?

This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05230511 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.